Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.76+0.22 (+0.86%)
Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%
Baxter International total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Baxter International's total debt was $844.00M at Sep 30, 2026. For fiscal 2025 it was $9.48B, down 27.8% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $17.66B in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.48B | -27.8% |
| FY2024 | Dec 31, 2024 | $13.13B | -4.6% |
| FY2023 | Dec 31, 2023 | $13.76B | -17.3% |
| FY2022 | Dec 31, 2022 | $16.64B | -5.8% |
| FY2021 | Dec 31, 2021 | $17.66B | +185.2% |
| FY2020 | Dec 31, 2020 | $6.19B | +15.7% |
| FY2019 | Dec 31, 2019 | $5.35B | +53.5% |
| FY2018 | Dec 31, 2018 | $3.49B | -0.8% |
| FY2017 | Dec 31, 2017 | $3.51B | +26.2% |
| FY2016 | Dec 31, 2016 | $2.78B | -57.2% |
| FY2015 | Dec 31, 2015 | $6.51B | -27.9% |
| FY2014 | Dec 31, 2014 | $9.03B | -1.5% |
| FY2013 | Dec 31, 2013 | $9.17B | +54.6% |
| FY2012 | Dec 31, 2012 | $5.93B | +14.1% |
| FY2011 | Dec 31, 2011 | $5.20B | +18.4% |
| FY2010 | Dec 31, 2010 | $4.39B | +5.7% |
| FY2009 | Dec 31, 2009 | $4.15B | +16.3% |
| FY2008 | Dec 31, 2008 | $3.57B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $844.00M | +11.8% |
| Q2 FY2026 | Jun 30, 2026 | $844.00M | +10450.0% |
| Q1 FY2026 | Mar 31, 2026 | $842.00M | +27.2% |
| Q4 FY2025 | Dec 31, 2025 | $9.48B | -27.8% |
| Q3 FY2025 | Sep 30, 2025 | $755.00M | -94.2% |
| Q2 FY2025 | Jun 30, 2025 | $8.00M | -99.9% |
| Q1 FY2025 | Mar 31, 2025 | $662.00M | -95.2% |
| Q4 FY2024 | Dec 31, 2024 | $13.13B | -4.6% |
| Q3 FY2024 | Sep 30, 2024 | $12.94B | -21.6% |
| Q2 FY2024 | Jun 30, 2024 | $12.90B | -21.7% |
| Q1 FY2024 | Mar 31, 2024 | $13.73B | -16.5% |
| Q4 FY2023 | Dec 31, 2023 | $13.76B | -17.3% |
| Q3 FY2023 | Sep 30, 2023 | $16.49B | +0.4% |
| Q2 FY2023 | Jun 30, 2023 | $16.48B | +3940.0% |
| Q1 FY2023 | Mar 31, 2023 | $16.43B | +3917.4% |
| Q4 FY2022 | Dec 31, 2022 | $16.64B | -5.8% |
| Q3 FY2022 | Sep 30, 2022 | $16.43B | +3122.0% |
| Q2 FY2022 | Jun 30, 2022 | $408.00M | -10.7% |
| Q1 FY2022 | Mar 31, 2022 | $409.00M | +0.5% |
| Q4 FY2021 | Dec 31, 2021 | $17.66B | +185.2% |
| Q3 FY2021 | Sep 30, 2021 | $510.00M | -29.8% |
| Q2 FY2021 | Jun 30, 2021 | $457.00M | +43.3% |
| Q1 FY2021 | Mar 31, 2021 | $407.00M | -24.1% |
| Q4 FY2020 | Dec 31, 2020 | $6.19B | +15.7% |
| Q3 FY2020 | Sep 30, 2020 | $727.00M | +36250.0% |
| Q2 FY2020 | Jun 30, 2020 | $319.00M | -93.8% |
| Q1 FY2020 | Mar 31, 2020 | $536.00M | -87.4% |
| Q4 FY2019 | Dec 31, 2019 | $5.35B | +53.5% |
| Q3 FY2019 | Sep 30, 2019 | $2.00M | -99.9% |
| Q2 FY2019 | Jun 30, 2019 | $5.16B | +47.7% |
| Q1 FY2019 | Mar 31, 2019 | $4.25B | +19.6% |
| Q4 FY2018 | Dec 31, 2018 | $3.49B | -0.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.48B | -0.4% |
| Q2 FY2018 | Jun 30, 2018 | $3.49B | +1.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.55B | +27.5% |
| Q4 FY2017 | Dec 31, 2017 | $3.51B | +26.2% |
| Q3 FY2017 | Sep 30, 2017 | $3.50B | – |
| Q2 FY2017 | Jun 30, 2017 | $3.46B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.79B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.78B | – |
See a number that looks wrong?